The Japanese Animal Health Market
50% DISCOUNT

Identify and exploit growth areas in this key market worth over US$1 billion with Animal Pharm's new 127-page report.

As the world's second largest market for animal health product sales, representation for international companies in Japan is crucial. Yet, the effect of world trade agreements and difficult economic conditions demand that companies currently active in or looking to enter the Japanese market require 'insider' knowledge.

Combining comprehensive company and market analysis, The Japanese Animal Health Market provides the reader with a complete evaluation of current and predicted operating conditions.

This report contains:

Company Information

Market information

Ensure that you're in a position to exploit market opportunities to their fullest potential with a copy of The Japanese Animal Health Market.

Published: May 1996
Ref: SR154E
Pages: 127
Price: £150/$315/¥36,000


CONTENTS

INTRODUCTION

CHAPTER1 1.1 Geography
1.2 Economy
1.3 Agriculture
1.3.1 The livestock sector
1.3.2 The Uruguay Round agreement

CHAPTER 2 ANIMAL NUMBERS, PRODUCTION & CONSUMPTION
2.1 Introduction
2.2 The livestock sector
2.2.1 Poultry
2.2.2 Pigs
2.2.3 Cattle
2.3 The companion animal sector
2.3.1 Horses
2.3.2 Dogs and cats
2.4 Japan's veterinary profession

CHAPTER 3 THE ANIMAL HEALTH PRODUCTS MARKET
3.1 Introduction
3.2 Development of the market
3.2.1 Market value
3.2.2 Recent trends in market value
3.3 Market structure by product category
3.3.1 Pharmaceuticals
3.3.2 Biologicals
3.3.3 Feed additives
3.4 Market structure by species
3.5 Future market prospects
3.5.1 Changes in market value
3.5.2 Changes in market structure by species
3.5.3 Changes in market structure by product

CHAPTER 4 MAJOR COMPANY PROFILES
4.1 Introduction
4.2 Leading company profiles
Daiichi
Dainippon
Eisai
Kyoritsu Shoji
Meiji Seika Kaisha
Nippon Zenyaku Kogyo
Pfizer
Sankyo
Shionogi
Takeda
Kyowa Hakko
Tanabe
Fujisawa
Nippon Roche
Mitaka
Kaketsuken Institute
Bayer
Denka
Fujihira Industries
Sumitomo

CHAPTER 4.3 FOREIGN COMPANY ACTIVITIES
4.3.1 Bayer
4.3.2 Ciba
4.3.3 Elanco
4.3.4 Fort Dodge
4.3.5 Hoechst
4.3.6 Intervet
4.3.7 Mallinckrodt
4.3.8 Merck AgVet
4.3.9 Pfizer
4.3.10 Rhône Mèrieux
4.3.11 Roche
4.3.12 Schering-Plough
4.3.13 Solvay
4.3.14 Upjohn

CHAPTER 5 REGULATION OF ANIMAL HEALTH PRODUCTS
5.1 Registration of pharmaceuticals & biologicals
5.1.1 New drug approvals
5.1.2 Vaccine registration requirements
5.2 Registration of feed additives
5.3 Distribution
5.4 Regulatory issues
5.4.1 Changing regulations
5.4.2 International harmonisation

Appendix - company addresses

Information sources


© PJB Publications Ltd. 2000
All rights reserved.